Bone turnover and periprosthetic bone loss after cementless total hip arthroplasty can be restored by zoledronic acid: a prospective, randomized, open-label, controlled trial

Bone turnover and periprosthetic bone loss after cementless total hip arthroplasty can be restored by zoledronic acid: a prospective, randomized, open-label, controlled trial

Abstract Background Although the loss of bone mineral density (BMD) after total hip arthroplasty (THA) is a known problem, it remains unresolved. This study prospectively examined the effect of zoledronic acid (ZA) on bone turnover and BMD after cementless THA. Methods Between January 2010 and Augus...

Full description

Bibliographic Details
Main Authors: Tsan-Wen Huang, Chao-Jan Wang, Hsin-Nung Shih, Yuhan Chang, Kuo-Chin Huang, Kuo-Ti Peng, Mel S. Lee
Format: Article
Language:English
Published: BMC 2017-05-01
Series:BMC Musculoskeletal Disorders
Subjects:
Cementless total hip arthroplasty
Bone mineral density
Bisphosphonate
Stress shielding
Zoledronic acid
Bone turnover markers
Online Access:http://link.springer.com/article/10.1186/s12891-017-1577-2

Internet

http://link.springer.com/article/10.1186/s12891-017-1577-2

Similar Items